U.S. scientists are testing the effectiveness of a bioengineered "construct" that uses stem cells derived from bone marrow and a genetic product that halts tumor progression in targeting pancreatic cancer without causing harm to healthy tissue. The treatment, which is in preliminary development, works by confusing and inducing tumor cells to produce a toxic product.

Related Summaries